Cognitive and Memory Enhancer Drugs Market – Global Industry Analysis and Forecast (2023-2029) by Type, Application and Region


Cognitive and Memory Enhancer Drugs Market is expected to reach US$ 8.34 Bn. at a CAGR of 5.68% during the forecast period 2029.

Cognitive and Memory Enhancer Drugs Market Overview:

Attempts to improve cognitive function in patients with brain disorders has become the focus of intensive research. Cognitive and Memory Enhancer Drugs are used to improve memory, increase mental alertness, enhance concentration, and boost the energy levels of an individual. Some cognitive enhancers are designed to treat conditions such as sleepiness or narcolepsy and to improve attention and focus in people with attention disorders.

Cognitive and Memory Enhancer Drugs MarketTo Know About The Research Methodology :- Request Free Sample Report

Cognitive and Memory Enhancer Drugs Market Dynamics:

Rising prevalence of neurological disorders is the key driving factor for the market growth.

Incidences of neurological disorders like dementia, Alzheimer and Parkinson’s increase demand a reliable treatment. Hence, the individuals affected with these disorders are the prominent receivers of cognitive and memory enhancer drugs. This factor propels the market growth. Worldwide, around 50 million people have dementia, and there are nearly 10 million new cases every year. Besides this, cognitive drugs are also used in the field of academics and athletics. Also, ongoing clinical trials for the development of potential drugs contribute to the market growth. The high cost involved in the R&D activities of the drugs and legal & ethical contradictions may affect the market negatively in the forecast period.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and the report has come up with recommendations for a future hot spot in the APAC region.

Cognitive and Memory Enhancer Drugs Market Segment Analysis:

Based on the product, the Namenda held the largest share of xx% in 2022 and is expected to dominate during forecast years. It is the first drug approved for Alzheimer's and dementia by the FDA and helps in slowing down the disease progression. Memantine (Namenda) and a combination of Memantine and donepezil (Namzaric) are approved by the FDA for the treatment of moderate to severe Alzheimer’s. Namenda regulates the activity of glutamate, a chemical involved in information processing, storage, and retrieval, and also improves mental function and ability to perform daily activities for some people. New psychostimulant modafinil (Provigil) has been approved by FDA for improving alertness, a key factor in cognitive performance.

Based on the application, the academic performance segment is expected to dominate the global market during the forecast period. The academic performance segment is projected to register the fastest growth at a CAGR of 10.2% during the forecast period, owing to the benefits provided by these drugs to students in terms of improvement of concentration, memory, and performance. Also, the disease treatment segment is expected to be the fastest-growing segment owing to the increase in the prevalence of Asthma, Parkinson's, and Alzheimer's disease.

Cognitive and Memory Enhancer Drugs Market Regional Insights

North America anticipated to dominate the global market, followed by Europe.

Increasing Alzheimer’s patient pool in the region and increased healthcare expenditure for the long-term care of these patients drives the market growth in this region. More than 6 million Americans of all ages have Alzheimer's. An estimated 6.2 million Americans age 65 and older are living with Alzheimer's dementia in 2021. Apart from this, rising awareness amongst the people due to government initiatives undertaken about cognitive diseases fuels the market growth.

Asia Pacific is expected to witness lucrative growth:

The region is expected to witness the fastest growth owing to the rising adoption of cognitive drugs as there is an increasing geriatric population, especially in affluent countries of the region like Japan and India. Improved medical infrastructure, increased healthcare expenditure, medical tourism presence of large target population suffering from dementia, improved standard of living, and rise in disposable income drives the market.

The report also helps in understanding Global Cognitive and Memory Enhancer Drugs Market dynamics, structure by analyzing the market segments and project the Global Cognitive and Memory Enhancer Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cognitive and Memory Enhancer Drugs Market make the report investor’s guide.

Cognitive and Memory Enhancer Drugs Market Scope: Inquire before buying






Cognitive and Memory Enhancer Drugs Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 5.66 Bn.




Forecast Period 2023 to 2029 CAGR:
5.68%
Market Size in 2029:
US $ 8.34 Bn.




 Segments Covered:
by Product
• Namenda
• Provigil
• Aricept
• Razadyne
• Exelon
• Adderall
• Ritalin
• Others




by Application
• Disease Treatment
• Athletic Performance
• Academic Performance






Cognitive and Memory Enhancer Drugs Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)FWI

Cognitive and Memory Enhancer Drugs Market Key Players:

• Johnson & Johnson
• Pfizer Inc.
• Novartis AG
• Eisai Co., Ltd.
• Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.)
• AlternaScript LLC
• Shire
• Ceretropic
• Allergan Plc.
• Takeda Pharmaceutical Company

Frequently Asked Questions:

1. Which region has the largest share in Global Cognitive and Memory Enhancer Drugs Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Cognitive and Memory Enhancer Drugs Market?
Ans: The Global Cognitive and Memory Enhancer Drugs Market is expected to grow at a CAGR of 5.68% during forecast period 2023-2029.

3. What is scope of the Global Cognitive and Memory Enhancer Drugs market report?
Ans: Global Cognitive and Memory Enhancer Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Cognitive and Memory Enhancer Drugs market?
Ans: The important key players in the Global Cognitive and Memory Enhancer Drugs Market are – Johnson & Johnson, Pfizer Inc., Novartis AG, Eisai Co., Ltd., Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.), AlternaScript LLC, Shire, Ceretropic, Allergan Plc., and Takeda Pharmaceutical Company.

5. What is the study period of this market?
Ans: The Global Cognitive and Memory Enhancer Drugs Market is studied from 2022 




Table of Content
1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Cognitive and Memory Enhancer Drugs Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Cognitive and Memory Enhancer Drugs Market
3.4. Geographical Snapshot of the Cognitive and Memory Enhancer Drugs Market, By Manufacturer share
4. Global Cognitive and Memory Enhancer Drugs Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Cognitive and Memory Enhancer Drugs Market
5. Supply Side and Demand Side Indicators
6. Global Cognitive and Memory Enhancer Drugs Market Analysis and Forecast, 2022-2029
6.1. Global Cognitive and Memory Enhancer Drugs Market Size & Y-o-Y Growth Analysis.
7. Global Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
7.1.1. Namenda
7.1.2. Provigil
7.1.3. Aricept
7.1.4. Razadyne
7.1.5. Exelon
7.1.6. Adderall
7.1.7. Ritalin
7.1.8. Others
7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
7.2.1. Disease Treatment
7.2.2. Athletic Performance
7.2.3. Academic Performance
8. Global Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
9.1.1. Namenda
9.1.2. Provigil
9.1.3. Aricept
9.1.4. Razadyne
9.1.5. Exelon
9.1.6. Adderall
9.1.7. Ritalin
9.1.8. Others
9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
9.2.1. Disease Treatment
9.2.2. Athletic Performance
9.2.3. Academic Performance
10. North America Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
12. Canada Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
13. Mexico Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
14. Europe Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
15. Europe Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
17. France Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
18. Germany Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
19. Italy Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
20. Spain Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
21. Sweden Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
22. CIS Countries Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
23. Rest of Europe Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
24. Asia Pacific Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
25. Asia Pacific Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
27. India Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
28. Japan Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
29. South Korea Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
30. Australia Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
31. ASEAN Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
32. Rest of Asia Pacific Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
33. Middle East Africa Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
34. Middle East Africa Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
36. GCC Countries Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
37. Egypt Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
38. Nigeria Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
39. Rest of ME&A Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
40. South America Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
41. South America Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
43. Argentina Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
44. Rest of South America Cognitive and Memory Enhancer Drugs Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Cognitive and Memory Enhancer Drugs Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Applications
45.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
45.3. Company Profile - Johnson & Johnson
45.3.1. Company Overview
45.3.2. Financial Overview
45.3.3. Geographic Footprint
45.3.4. Product Portfolio
45.3.5. Business Strategy
45.3.6. Recent Developments
45.4. Pfizer Inc.
45.5. Novartis AG
45.6. Eisai Co., Ltd.
45.7. Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.)
45.8. AlternaScript LLC
45.9. Shire
45.10. Ceretropic
45.11. Allergan Plc.
45.12. Takeda Pharmaceutical Company
46. Primary Key Insights
  • INQUIRE BEFORE BUYING